Please enable JavaScript to continue using this application.

Compare $CGEM vs $KURA | Chartloom

Compare

$CGEM vs $KURA

Cullinan Therapeutics Inc · Kura Oncology Inc

CGEM

Cullinan Therapeutics Inc

KURA

Kura Oncology Inc

Compare $CGEM vs $KURA

Comparing Cullinan Therapeutics Inc and Kura Oncology Inc

CGEMCullinan Therapeutics Inc

KURAKura Oncology Inc

CGEMCullinan Therapeutics Inc

Market cap

$954M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.5%

52W performance

140.8%

FCF yield

-16.7%

KURAKura Oncology Inc

Market cap

$941M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.49x

Rev growth (TTM)

-7.3%

YTD performance

2.6%

52W performance

5.2%

FCF yield

-12.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGEM

KURA

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

KURA

Kura Oncology Inc

Market Cap

CGEM$954M

KURA$941M

Enterprise Value

CGEM$876M

KURA$881M

Price

CGEM$15.53

KURA$10.60

P/E Ratio

CGEMN/A

KURAN/A

P/S Ratio

CGEM0.00x

KURA12.18x

EV/Sales

CGEM0.00x

KURA11.40x

EV/EBITDA

CGEM8.02x

KURA0.00x

P/B Ratio

CGEM3.10x

KURA19.56x

P/FCF Ratio

CGEMN/A

KURAN/A

EV/FCF

CGEM-5.50x

KURA-7.50x

PEG Ratio

CGEMN/A

KURAN/A

Forward P/E (NTM)

CGEMN/A

KURAN/A

Forward P/S (NTM)

CGEMN/A

KURA6.49x

Revenue (TTM)

CGEM$0

KURA$77M

Revenue Growth (YoY)

CGEMN/A

KURA-7.3%

Forward Rev Growth

CGEM244.6%

KURA106.3%

Gross Margin (TTM)

CGEM0.0%

KURA72.4%

Operating Margin (TTM)

CGEM0.0%

KURA0.0%

EBITDA Margin (TTM)

CGEM0.0%

KURA-410.2%

Net Margin (TTM)

CGEM0.0%

KURA-384.3%

FCF Margin (TTM)

CGEMN/A

KURA-152.1%

Net Income (TTM)

CGEM$-205M

KURA$-297M

FCF (TTM)

CGEM$-159M

KURA$-117M

EPS (TTM)

CGEM-$3.33

KURA-$3.34

ROE (TTM)

CGEM-5289.0%

KURA-20718.0%

ROA (TTM)

CGEM-4818.0%

KURA-4517.0%

ROIC (TTM)

CGEM-5289.0%

KURA-19400.0%

Cash

CGEM$79M

KURA$70M

Debt

CGEM$0

KURA$10M

Net Cash/Debt

CGEM$79M

KURA$60M

Current Ratio (TTM)

CGEM8.42x

KURA4.73x

Quick Ratio (TTM)

CGEM8.23x

KURA4.47x

Debt/Equity (TTM)

CGEM0.00x

KURA0.20x

Debt/Assets (TTM)

CGEM0.0%

KURA0.0%

Interest Coverage (TTM)

CGEMN/A

KURAN/A

Net Debt/EBITDA (TTM)

CGEM0.00x

KURA0.00x

Beta

CGEM-0.03

KURA0.53

52W Performance

CGEM140.8%

KURA5.2%

YTD Performance

CGEM53.5%

KURA2.6%

% from 52W High

CGEM-33.0%

KURA-23.7%

% from 52W Low

CGEM138.9%

KURA44.1%

Asset Turnover (TTM)

CGEM0.00x

KURA0.12x

FCF Yield (TTM)

CGEM-16.7%

KURA-12.5%

Earnings Yield (TTM)

CGEM-21.4%

KURA-31.5%

Dividend Yield (TTM)

CGEMN/A

KURAN/A

Rule of 40

CGEM0.0

KURA-159.3

EV/GP/RG

CGEMN/A

KURA0.09

Ticker research

View CGEM research View KURA research

Metric	CGEM Cullinan Therapeutics Inc	KURA Kura Oncology Inc
Market & Valuation
Market Cap	$954M	$941M
Enterprise Value	$876M	$881M
Price	$15.53	$10.60
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	12.18x
EV/Sales	0.00x	11.40x
EV/EBITDA	8.02x	0.00x
P/B Ratio	3.10x	19.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.50x	-7.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.49x
Revenue & Growth
Revenue (TTM)	$0	$77M
Revenue Growth (YoY)	N/A	-7.3%
Forward Rev Growth	244.6%	106.3%
Profitability
Gross Margin (TTM)	0.0%	72.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-410.2%
Net Margin (TTM)	0.0%	-384.3%
FCF Margin (TTM)	N/A	-152.1%
Net Income (TTM)	$-205M	$-297M
FCF (TTM)	$-159M	$-117M
EPS (TTM)	-$3.33	-$3.34
ROE (TTM)	-5289.0%	-20718.0%
ROA (TTM)	-4818.0%	-4517.0%
ROIC (TTM)	-5289.0%	-19400.0%
Financial Health
Cash	$79M	$70M
Debt	$0	$10M
Net Cash/Debt	$79M	$60M
Current Ratio (TTM)	8.42x	4.73x
Quick Ratio (TTM)	8.23x	4.47x
Debt/Equity (TTM)	0.00x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	0.53
52W Performance	140.8%	5.2%
YTD Performance	53.5%	2.6%
% from 52W High	-33.0%	-23.7%
% from 52W Low	138.9%	44.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.12x
FCF Yield (TTM)	-16.7%	-12.5%
Earnings Yield (TTM)	-21.4%	-31.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-159.3
EV/GP/RG	N/A	0.09
Ticker research	View CGEM research	View KURA research

Valuation

P/S Ratio

CGEM

0.00x

KURA

12.18x

EV/FCF

KURA

-7.50x

CGEM

-5.50x

Growth & revenue

Revenue Growth TTM

KURA

-7.3%

Forward Revenue Growth

CGEM

244.6%

KURA

106.3%

Profitability & performance

Gross Margin

KURA

72.4%

CGEM

0.0%

ROE

CGEM

-5289.0%

KURA

-20718.0%

FCF Yield %

KURA

-12.5%

CGEM

-16.7%

52-Week Performance

CGEM

140.8%

KURA

5.2%

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

KURA

Kura Oncology Inc

Market Cap

CGEM$954M

KURA$941M

Enterprise Value

CGEM$876M

KURA$881M

Price

CGEM$15.53

KURA$10.60

P/E Ratio

CGEMN/A

KURAN/A

P/S Ratio

CGEM0.00x

KURA12.18x

EV/Sales

CGEM0.00x

KURA11.40x

EV/EBITDA

CGEM8.02x

KURA0.00x

P/B Ratio

CGEM3.10x

KURA19.56x

P/FCF Ratio

CGEMN/A

KURAN/A

EV/FCF

CGEM-5.50x

KURA-7.50x

PEG Ratio

CGEMN/A

KURAN/A

Forward P/E (NTM)

CGEMN/A

KURAN/A

Forward P/S (NTM)

CGEMN/A

KURA6.49x

Revenue (TTM)

CGEM$0

KURA$77M

Revenue Growth (YoY)

CGEMN/A

KURA-7.3%

Forward Rev Growth

CGEM244.6%

KURA106.3%

Gross Margin (TTM)

CGEM0.0%

KURA72.4%

Operating Margin (TTM)

CGEM0.0%

KURA0.0%

EBITDA Margin (TTM)

CGEM0.0%

KURA-410.2%

Net Margin (TTM)

CGEM0.0%

KURA-384.3%

FCF Margin (TTM)

CGEMN/A

KURA-152.1%

Net Income (TTM)

CGEM$-205M

KURA$-297M

FCF (TTM)

CGEM$-159M

KURA$-117M

EPS (TTM)

CGEM-$3.33

KURA-$3.34

ROE (TTM)

CGEM-5289.0%

KURA-20718.0%

ROA (TTM)

CGEM-4818.0%

KURA-4517.0%

ROIC (TTM)

CGEM-5289.0%

KURA-19400.0%

Cash

CGEM$79M

KURA$70M

Debt

CGEM$0

KURA$10M

Net Cash/Debt

CGEM$79M

KURA$60M

Current Ratio (TTM)

CGEM8.42x

KURA4.73x

Quick Ratio (TTM)

CGEM8.23x

KURA4.47x

Debt/Equity (TTM)

CGEM0.00x

KURA0.20x

Debt/Assets (TTM)

CGEM0.0%

KURA0.0%

Interest Coverage (TTM)

CGEMN/A

KURAN/A

Net Debt/EBITDA (TTM)

CGEM0.00x

KURA0.00x

Beta

CGEM-0.03

KURA0.53

52W Performance

CGEM140.8%

KURA5.2%

YTD Performance

CGEM53.5%

KURA2.6%

% from 52W High

CGEM-33.0%

KURA-23.7%

% from 52W Low

CGEM138.9%

KURA44.1%

Asset Turnover (TTM)

CGEM0.00x

KURA0.12x

FCF Yield (TTM)

CGEM-16.7%

KURA-12.5%

Earnings Yield (TTM)

CGEM-21.4%

KURA-31.5%

Dividend Yield (TTM)

CGEMN/A

KURAN/A

Rule of 40

CGEM0.0

KURA-159.3

EV/GP/RG

CGEMN/A

KURA0.09

Ticker research

View CGEM research View KURA research

Metric	CGEM Cullinan Therapeutics Inc	KURA Kura Oncology Inc
Market & Valuation
Market Cap	$954M	$941M
Enterprise Value	$876M	$881M
Price	$15.53	$10.60
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	12.18x
EV/Sales	0.00x	11.40x
EV/EBITDA	8.02x	0.00x
P/B Ratio	3.10x	19.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.50x	-7.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.49x
Revenue & Growth
Revenue (TTM)	$0	$77M
Revenue Growth (YoY)	N/A	-7.3%
Forward Rev Growth	244.6%	106.3%
Profitability
Gross Margin (TTM)	0.0%	72.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-410.2%
Net Margin (TTM)	0.0%	-384.3%
FCF Margin (TTM)	N/A	-152.1%
Net Income (TTM)	$-205M	$-297M
FCF (TTM)	$-159M	$-117M
EPS (TTM)	-$3.33	-$3.34
ROE (TTM)	-5289.0%	-20718.0%
ROA (TTM)	-4818.0%	-4517.0%
ROIC (TTM)	-5289.0%	-19400.0%
Financial Health
Cash	$79M	$70M
Debt	$0	$10M
Net Cash/Debt	$79M	$60M
Current Ratio (TTM)	8.42x	4.73x
Quick Ratio (TTM)	8.23x	4.47x
Debt/Equity (TTM)	0.00x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	0.53
52W Performance	140.8%	5.2%
YTD Performance	53.5%	2.6%
% from 52W High	-33.0%	-23.7%
% from 52W Low	138.9%	44.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.12x
FCF Yield (TTM)	-16.7%	-12.5%
Earnings Yield (TTM)	-21.4%	-31.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-159.3
EV/GP/RG	N/A	0.09
Ticker research	View CGEM research	View KURA research